These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 30516834)

  • 1. Short-term response to phenytoin sodium in Andersen-Tawil syndrome-1 with a cardiac-dominant phenotype.
    Rai MK; Pai R; Prabhu MA; Pasha SW; Kedambadi RC; Kamath P; Augustine AJ; Bhavani GS; Girisha KM
    Pacing Clin Electrophysiol; 2019 Feb; 42(2):201-207. PubMed ID: 30516834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of flecainide for ventricular arrhythmias in patients with Andersen-Tawil syndrome with KCNJ2 mutations.
    Miyamoto K; Aiba T; Kimura H; Hayashi H; Ohno S; Yasuoka C; Tanioka Y; Tsuchiya T; Yoshida Y; Hayashi H; Tsuboi I; Nakajima I; Ishibashi K; Okamura H; Noda T; Ishihara M; Anzai T; Yasuda S; Miyamoto Y; Kamakura S; Kusano K; Ogawa H; Horie M; Shimizu W
    Heart Rhythm; 2015 Mar; 12(3):596-603. PubMed ID: 25496985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genotype-phenotype correlations of KCNJ2 mutations in Japanese patients with Andersen-Tawil syndrome.
    Haruna Y; Kobori A; Makiyama T; Yoshida H; Akao M; Doi T; Tsuji K; Ono S; Nishio Y; Shimizu W; Inoue T; Murakami T; Tsuboi N; Yamanouchi H; Ushinohama H; Nakamura Y; Yoshinaga M; Horigome H; Aizawa Y; Kita T; Horie M
    Hum Mutat; 2007 Feb; 28(2):208. PubMed ID: 17221872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel mutation in the KCNJ2 gene is associated with a malignant arrhythmic phenotype of Andersen-Tawil syndrome.
    Fernlund E; Lundin C; Hertervig E; Kongstad O; Alders M; Platonov P
    Ann Noninvasive Electrocardiol; 2013 Sep; 18(5):471-8. PubMed ID: 24047492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional analysis of a double-point mutation in the KCNJ2 gene identified in a family with Andersen-Tawil syndrome.
    Fukumura S; Yamauchi K; Kawanabe A; Yamamoto A; Nakaza M; Kubota T; Kato S; Sasaki R; Okamura Y; Takahashi MP
    J Neurol Sci; 2019 Dec; 407():116521. PubMed ID: 31669729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Andersen-Tawil syndrome: report of 3 novel mutations and high risk of symptomatic cardiac involvement.
    Kostera-Pruszczyk A; Potulska-Chromik A; Pruszczyk P; Bieganowska K; Miszczak-Knecht M; Bienias P; Szczałuba K; Lee HY; Quinn E; Ploski R; Kaminska A; Ptáček LJ
    Muscle Nerve; 2015 Feb; 51(2):192-6. PubMed ID: 24861851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Andersen-Tawil syndrome: Clinical presentation and predictors of symptomatic arrhythmias - Possible role of polymorphisms K897T in KCNH2 and H558R in SCN5A gene.
    Krych M; Biernacka EK; Ponińska J; Kukla P; Filipecki A; Gajda R; Hasdemir C; Antzelevitch C; Kosiec A; Szperl M; Płoski R; Trusz-Gluza M; Mizia-Stec K; Hoffman P
    J Cardiol; 2017 Nov; 70(5):504-510. PubMed ID: 28336205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sudden cardiac death in Andersen-Tawil syndrome.
    Peters S; Schulze-Bahr E; Etheridge SP; Tristani-Firouzi M
    Europace; 2007 Mar; 9(3):162-6. PubMed ID: 17272325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Andersen-Tawil syndrome. Efficacy of class IC drugs].
    Makarov LM; Komoliatova VN; Kolosov VO; Fedina NN; Solokhin IuA
    Kardiologiia; 2013; 53(1):91-6. PubMed ID: 23548357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac characteristics and long-term outcome in Andersen-Tawil syndrome patients related to KCNJ2 mutation.
    Delannoy E; Sacher F; Maury P; Mabo P; Mansourati J; Magnin I; Camous JP; Tournant G; Rendu E; Kyndt F; Haïssaguerre M; Bézieau S; Guyomarch B; Le Marec H; Fressart V; Denjoy I; Probst V
    Europace; 2013 Dec; 15(12):1805-11. PubMed ID: 23867365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel neuropsychiatric phenotype of KCNJ2 mutation in one Taiwanese family with Andersen-Tawil syndrome.
    Chan HF; Chen ML; Su JJ; Ko LC; Lin CH; Wu RM
    J Hum Genet; 2010 Mar; 55(3):186-8. PubMed ID: 20111058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different responses to exercise between Andersen-Tawil syndrome and catecholaminergic polymorphic ventricular tachycardia.
    Inoue YY; Aiba T; Kawata H; Sakaguchi T; Mitsuma W; Morita H; Noda T; Takaki H; Toyohara K; Kanaya Y; Itoi T; Mitsuhashi T; Sumitomo N; Cho Y; Yasuda S; Kamakura S; Kusano K; Miyamoto Y; Horie M; Shimizu W
    Europace; 2018 Oct; 20(10):1675-1682. PubMed ID: 29309601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and neurophysiological variability in Andersen-Tawil syndrome.
    Kokubun N; Aoki R; Nagashima T; Komagamine T; Kuroda Y; Horie M; Hirata K
    Muscle Nerve; 2019 Dec; 60(6):752-757. PubMed ID: 31509255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Andersen-Tawil syndrome with early fixed myopathy.
    Lefter S; Hardiman O; Costigan D; Lynch B; McConville J; Hand CK; Ryan AM
    J Clin Neuromuscul Dis; 2014 Dec; 16(2):79-82. PubMed ID: 25415519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotype variability in patients carrying KCNJ2 mutations.
    Kimura H; Zhou J; Kawamura M; Itoh H; Mizusawa Y; Ding WG; Wu J; Ohno S; Makiyama T; Miyamoto A; Naiki N; Wang Q; Xie Y; Suzuki T; Tateno S; Nakamura Y; Zang WJ; Ito M; Matsuura H; Horie M
    Circ Cardiovasc Genet; 2012 Jun; 5(3):344-53. PubMed ID: 22589293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of any cardiac involvement in a patient with Andersen-Tawil syndrome associated with the c.574A→G mutation in KCNJ2.
    Modoni A; Bianchi ML; Vitulano N; Pagliarani S; Perna F; Sanna T; Rizzo V; Silvestri G
    Cardiology; 2011; 120(4):200-3. PubMed ID: 22286118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of the intravenous flecainide challenge test before oral flecainide treatment in a patient with Andersen-Tawil syndrome.
    Sato A; Takano T; Chinushi M; Minamino T
    BMJ Case Rep; 2019 Jul; 12(7):. PubMed ID: 31311787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrafamilial phenotypic variability in Andersen-Tawil syndrome: A diagnostic challenge in a potentially treatable condition.
    Ardissone A; Sansone V; Colleoni L; Bernasconi P; Moroni I
    Neuromuscul Disord; 2017 Mar; 27(3):294-297. PubMed ID: 28024840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mosaic KCNJ2 mutation in Andersen-Tawil syndrome: targeted deep sequencing is useful for the detection of mosaicism.
    Hasegawa K; Ohno S; Kimura H; Itoh H; Makiyama T; Yoshida Y; Horie M
    Clin Genet; 2015 Mar; 87(3):279-83. PubMed ID: 24635491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Andersen-Tawil syndrome: clinical and molecular aspects.
    Nguyen HL; Pieper GH; Wilders R
    Int J Cardiol; 2013 Dec; 170(1):1-16. PubMed ID: 24383070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.